University of Ioannina
Προοπτική μελέτη της επίπτωσης, της σοβαρότητας και της μεταβολής στο χρόνο των νευρογνωσιακών δυσλειτουργιών σε γυναίκες με πρώιμο καρκίνο μαστού που λαμβάνουν επικουρική χημειοθεραπεία (Chemo Brain): αντίκτυπος στην ποιότητα ζωής και συσχέτιση με κλινικά χαρακτηριστικά
Abstract
dc:descriptionThe aim of this study is to record the resulting immediate and long-term neuropsychologica complications from treatment with intravenous cytotoxic chemotherapy in women with breast cancer," order to clarify their severity and frequency. Also, the impact of these complications on patients' qually of life, as well as their association with clinical features. The 114 women included in the present study were divided into three groups: healthy women (N = 20), breast cancer patients on adjuvant chemotherapy without chemotherapy (N = 20), and patients with breast cancer under adjuvant chemotherapy (N = 74). All participants completed the selected neurological tests (healthy women CES-D, Mini Mental State Examination and MOCA), while the effects of breast cancer and the followed treatment on the quality of life of the patients in our sample were evaluated and compared with EORTCQLQ.-C30 and QLQ-BR23 tests, in two time periods, one year apart. The present study showed that the type of followed treatment (chemotherapy or hormone therapy) has a significant impact on both the depressive symptoms of patients and to a lesser extent) the cognitive impairment. Patients undergoing chemotherapy showed a most severe impact in both areas, which in fact deteriorates in the second assessment. Age, occupational status, educational level, staging and differentiation of tumor, appear to affect both the observed impairment of cognitive functions and the depressive symptoms of patient groups. No statistically significant correlation was recorded between levels of depression and cognitive functions for both groups of patients. These reverberations appeared to affect patients' quality of life. Especially in patients receiving adjuvant chemotherapy, there was a clear deterioration in Cognitive Functionality and poorer quality of life during the second assessment. In contrast, for patients on adjuvant hormone therapy, a significant improvement in role-related functionality (Role Functioning-RF) was observed, symptoms of nausea vomiting, pain and loss of appetite decreased, and diarrhea symptoms increased, but the overall picture was that their quality of life was not significantly affected.
Degree
thesis:*- Grantor dc:publisher
- University of Ioannina
- Year dc:date
- 2020
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Masoura, Foteini
- Μασούρα, Φωτεινή
Subjects
dc:subject × 13Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/48021